Author
The Ohio State UniversityORCID 0000-0002-1151-5427Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Rui Yang, Noura Srour, Pankajavalli Thirugnanasambandam…·Pui-Kai Li
The paper designs and evaluates amino-acid-derived PP2A activators, identifies XML-3D as a lead compound with improved cytotoxicity compared to FTY-720 and OSU-2S.
Soo‐Yeon Hwang, Helgi Nikoli, Belem Yoval‐Sánchez…·Jihye Paik
This study identifies BRG1-driven ferroptosis resistance as a mechanism of BTKi resistance in MCL and shows that BRG1 inhibition restores ferroptotic sensitivity and synergizes with BTKi.
Chinmayee Goda, Rohan SUDHIR Kulkarni, Yaphet Bustos…·Adrienne M. Dorrance
The paper identifies changes in the bone marrow microenvironment during preleukemic stages of AML, including an expanded CD55+ fibroblast population that supports preleukemic stem cells over normal HSCs.
Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita…·Philip N. Tsichlis
This study identifies KDM2B's role in regulating amino acid metabolism through interactions with ncPRC1.1, MYC, and ATF4, revealing a metabolic network linked to poor prognosis in TNBC.
Neeraj Jain, Ondrej Havranek, Ram Kumar Singh…·Felipe Samaniego
This study identifies phosphatidylinositol-3-kinase-beta upregulation as a mechanism of ibrutinib resistance in diffuse large B-cell lymphoma and shows that targeting this pathway with KA2237 can overcome resistance.